receptor agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8952197
APP PUB NO 20120142967A1
SERIAL NO

13378797

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to processes and intermediates useful in the preparation of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin), a serotonin (5-HT) receptor modulator that is useful in the treatment of for example, central nervous system disorders, such as obesity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARENA PHARMACEUTICALS INC6166 NANCY RIDGE DRIVE SAN DIEGO CA 92121

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Castro, Ryan O San Diego, US 8 65
Chuang, Tsung-Hsun San Diego, US 7 33
DeMattei, John A Berthoud, US 13 111
Hadd, Mark Allen San Diego, US 8 55
Lu, Xiao-Xiong San Diego, US 3 21
Macias, Mark San Diego, US 12 96
Marlon, Carlos Chula Vista, US 2 1
Shaw, Stephen M San Diego, US 2 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 10, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00